E. Vallée

571 total citations
7 papers, 470 citations indexed

About

E. Vallée is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, E. Vallée has authored 7 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Internal Medicine. Recurrent topics in E. Vallée's work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and Protein Kinase Regulation and GTPase Signaling (1 paper). E. Vallée is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and Protein Kinase Regulation and GTPase Signaling (1 paper). E. Vallée collaborates with scholars based in France. E. Vallée's co-authors include J.P. Maffrand, G. Defreyn, R. Roncucci, Jean‐Marc Herbert, D. Gouy, Yves Berger, J Necciari, G Kieffer, D. FREHEL and Jean‐Pierre Maffrand and has published in prestigious journals such as Journal of Pharmacy and Pharmacology, Thrombosis Research and Inflammation Research.

In The Last Decade

E. Vallée

7 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Vallée France	7	285	117	110	101	60	7	470
Denis Delebassée France	7	281 1.0×	116 1.0×	88 0.8×	136 1.3×	66 1.1×	9	457
H Weisenberger Germany	13	214 0.8×	95 0.8×	50 0.5×	78 0.8×	77 1.3×	21	463
JM Herbert France	8	256 0.9×	101 0.9×	95 0.9×	70 0.7×	67 1.1×	11	376
JP Maffrand France	7	277 1.0×	101 0.9×	97 0.9×	73 0.7×	65 1.1×	9	396
C.M. Ingerman-Wojenski United States	9	202 0.7×	105 0.9×	56 0.5×	118 1.2×	135 2.3×	12	578
M. Dubar France	10	318 1.1×	121 1.0×	68 0.6×	39 0.4×	98 1.6×	16	536
Sue Fox United Kingdom	14	283 1.0×	70 0.6×	91 0.8×	148 1.5×	103 1.7×	21	490
Taketoshi Ogawa Japan	14	541 1.9×	240 2.1×	147 1.3×	166 1.6×	118 2.0×	30	827
CM Ingerman United States	6	229 0.8×	64 0.5×	33 0.3×	127 1.3×	280 4.7×	9	675
Caterina Pettinella Italy	7	282 1.0×	86 0.7×	88 0.8×	38 0.4×	137 2.3×	7	528

Countries citing papers authored by E. Vallée

Since Specialization

Citations

This map shows the geographic impact of E. Vallée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Vallée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Vallée more than expected).

Fields of papers citing papers by E. Vallée

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Vallée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Vallée. The network helps show where E. Vallée may publish in the future.

Co-authorship network of co-authors of E. Vallée

This figure shows the co-authorship network connecting the top 25 collaborators of E. Vallée. A scholar is included among the top collaborators of E. Vallée based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Vallée. E. Vallée is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Herbert, Jean‐Marc, D. FREHEL, E. Vallée, et al.. (1993). Clopidogrel, A Novel Antiplatelet and Antithrombotic Agent. Cardiovascular Drug Reviews. 11(2). 180–198. 184 indexed citations

2.

Bernat, A., E. Vallée, J.P. Maffrand, & John L. Gordon. (1988). The role of platelets and ADP in experimental thrombosis induced by venous stasis in the rat. Thrombosis Research. 52(1). 65–70. 20 indexed citations

3.

Delebassée, Denis, Michel Simon, Hugues Chap, et al.. (1987). Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADP. Thrombosis Research. 48(4). 403–415. 65 indexed citations

4.

Bernat, A., E. Vallée, J.P. Maffrand, & R. Roncucci. (1985). Antithrombotic effect of ticlopidine in a platelet-independent model of venous thrombosis. Thrombosis Research. 37(2). 279–285. 21 indexed citations

5.

Panak, E, et al.. (1983). Ticlopidine: A Promise for the Prevention and Treatment of Thrombosis and Its Complications. Pathophysiology of Haemostasis and Thrombosis. 13(Suppl. 1). 1–54. 102 indexed citations

6.

Vallée, E., et al.. (1980). Inhibition of platelet phospholipase-A2 as a mechanism for the anti-aggregating effect of linoleic acid. Inflammation Research. 10(1-2). 57–62. 14 indexed citations

7.

Vallée, E., et al.. (1979). Anti-inflammatory and platelet anti-aggregant activity of phospholipase-A2 inhibitors. Journal of Pharmacy and Pharmacology. 31(1). 588–592. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact